Correlation Between AptaBio Therapeutics and Jeju Semiconductor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Jeju Semiconductor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Jeju Semiconductor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Jeju Semiconductor Corp, you can compare the effects of market volatilities on AptaBio Therapeutics and Jeju Semiconductor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Jeju Semiconductor. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Jeju Semiconductor.

Diversification Opportunities for AptaBio Therapeutics and Jeju Semiconductor

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between AptaBio and Jeju is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Jeju Semiconductor Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jeju Semiconductor Corp and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Jeju Semiconductor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jeju Semiconductor Corp has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Jeju Semiconductor go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Jeju Semiconductor

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 3.13 times less return on investment than Jeju Semiconductor. But when comparing it to its historical volatility, AptaBio Therapeutics is 1.33 times less risky than Jeju Semiconductor. It trades about 0.07 of its potential returns per unit of risk. Jeju Semiconductor Corp is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  864,000  in Jeju Semiconductor Corp on October 6, 2024 and sell it today you would earn a total of  103,000  from holding Jeju Semiconductor Corp or generate 11.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Jeju Semiconductor Corp

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Jeju Semiconductor Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jeju Semiconductor Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

AptaBio Therapeutics and Jeju Semiconductor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Jeju Semiconductor

The main advantage of trading using opposite AptaBio Therapeutics and Jeju Semiconductor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Jeju Semiconductor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jeju Semiconductor will offset losses from the drop in Jeju Semiconductor's long position.
The idea behind AptaBio Therapeutics and Jeju Semiconductor Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.